Roger Luddington

2.2k total citations
28 papers, 1.7k citations indexed

About

Roger Luddington is a scholar working on Hematology, Genetics and Internal Medicine. According to data from OpenAlex, Roger Luddington has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 9 papers in Genetics and 9 papers in Internal Medicine. Recurrent topics in Roger Luddington's work include Blood Coagulation and Thrombosis Mechanisms (19 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers). Roger Luddington is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (19 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers). Roger Luddington collaborates with scholars based in United Kingdom, Netherlands and France. Roger Luddington's co-authors include Trevor Baglin, Karen Brown, Caroline Baglin, David J. Williamson, Gillian Evans, Peter Baker, Stephen MacDonald, Jonathan Langdown, Andrew Jackson and Yesim Dargaud and has published in prestigious journals such as The Lancet, Blood and Transplantation.

In The Last Decade

Roger Luddington

27 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Luddington United Kingdom 18 1.1k 945 626 275 230 28 1.7k
R. Luddington United Kingdom 17 907 0.8× 620 0.7× 500 0.8× 326 1.2× 152 0.7× 26 1.7k
Patricia Vegh Canada 16 1.2k 1.1× 632 0.7× 404 0.6× 316 1.1× 123 0.5× 20 1.8k
Margareta Holmström Sweden 25 1.3k 1.2× 1.5k 1.6× 1.4k 2.2× 609 2.2× 182 0.8× 77 2.9k
Joost J. van Veen United Kingdom 19 532 0.5× 463 0.5× 442 0.7× 240 0.9× 131 0.6× 34 1.2k
Caroline Baglin United Kingdom 11 856 0.8× 1.1k 1.2× 885 1.4× 293 1.1× 150 0.7× 15 1.6k
Ian Jennings United Kingdom 23 839 0.8× 295 0.3× 310 0.5× 251 0.9× 143 0.6× 84 1.5k
H R Büller Netherlands 19 380 0.3× 807 0.9× 538 0.9× 342 1.2× 107 0.5× 46 1.4k
Simon McRae Australia 21 889 0.8× 742 0.8× 630 1.0× 385 1.4× 167 0.7× 60 1.7k
Dominique Lasne France 21 650 0.6× 330 0.3× 344 0.5× 562 2.0× 91 0.4× 93 1.4k
E. C. M. van Pampus Netherlands 19 664 0.6× 414 0.4× 263 0.4× 133 0.5× 84 0.4× 29 1.1k

Countries citing papers authored by Roger Luddington

Since Specialization
Citations

This map shows the geographic impact of Roger Luddington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Luddington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Luddington more than expected).

Fields of papers citing papers by Roger Luddington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Luddington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Luddington. The network helps show where Roger Luddington may publish in the future.

Co-authorship network of co-authors of Roger Luddington

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Luddington. A scholar is included among the top collaborators of Roger Luddington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Luddington. Roger Luddington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baglin, Trevor, et al.. (2016). Prolonged clot lysis time increases the risk of a first but not recurrent venous thrombosis. British Journal of Haematology. 172(6). 947–953. 18 indexed citations
2.
Langdown, Jonathan, Roger Luddington, James A. Huntington, & Trevor Baglin. (2014). A hereditary bleeding disorder resulting from a premature stop codon in thrombomodulin (p.Cys537Stop). Blood. 124(12). 1951–1956. 40 indexed citations
3.
Ortmann, Erik, A. A. Klein, Linda Sharples, et al.. (2013). Point-of-Care Assessment of Hypothermia and Protamine-Induced Platelet Dysfunction with Multiple Electrode Aggregometry (Multiplate®) in Patients Undergoing Cardiopulmonary Bypass. Anesthesia & Analgesia. 116(3). 533–540. 37 indexed citations
4.
Dargaud, Yesim, Alisa S. Wolberg, Roger Luddington, et al.. (2012). Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: An international multicentre study. Thrombosis Research. 130(6). 929–934. 104 indexed citations
5.
MacDonald, Stephen & Roger Luddington. (2010). Critical Factors Contributing to the Thromboelastography Trace. Seminars in Thrombosis and Hemostasis. 36(7). 712–722. 57 indexed citations
6.
Cardigan, Rebecca, et al.. (2009). Thrombin generation and clot formation in methylene blue–treated plasma and cryoprecipitate. Transfusion. 49(4). 696–703. 38 indexed citations
7.
Dargaud, Yesim, Roger Luddington, & Trevor Baglin. (2006). Platelet‐dependent thrombography: a method for diagnostic laboratories. British Journal of Haematology. 134(3). 323–325. 12 indexed citations
8.
Baglin, Trevor, Roger Luddington, Karen Brown, & Caroline Baglin. (2003). Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. The Lancet. 362(9383). 523–526. 476 indexed citations
9.
Evans, Gillian, Roger Luddington, & Trevor Baglin. (2001). Beriplex P/N reverses severe warfarin‐induced overanticoagulation immediately and completely in patients presenting with major bleeding. British Journal of Haematology. 115(4). 998–1001. 106 indexed citations
10.
Jackson, Andrew, Karen Brown, Jonathan Langdown, Roger Luddington, & Trevor Baglin. (2000). Effect of the angiotensin-converting enzyme gene deletion polymorphism on the risk of venous thromboembolism. SHORT REPORT. British Journal of Haematology. 111(2). 562–564. 36 indexed citations
11.
Luddington, Roger, et al.. (1999). Lupus Anticoagulant Testing with Optical End Point Automation. Thrombosis Research. 96(3). 197–203. 12 indexed citations
12.
Brown, Karen, Roger Luddington, Sherryl A. Taylor, David Lillicrap, & Trevor Baglin. (1999). Risk of venous thromboembolism associated with the common hereditary haemochromatosis Hfe gene (C282Y) mutation. British Journal of Haematology. 105(1). 95–97. 8 indexed citations
13.
Taube, Janis M., et al.. (1999). Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins. Blood. 93(11). 3792–3797. 37 indexed citations
14.
Brown, Karen, Roger Luddington, & Trevor Baglin. (1998). Effect of the MTHFRC677T variant on risk of venous thromboembolism: interaction with factor V Leiden and prothrombin (F2G20210A) mutations. British Journal of Haematology. 103(1). 42–44. 54 indexed citations
15.
Baglin, Caroline, et al.. (1998). Risk of recurrent venous thromboembolism in patients with the factor V Leiden (FVR506Q) mutation: effect of warfarin and prediction by precipitating factors. British Journal of Haematology. 100(4). 764–768. 38 indexed citations
16.
Baglin, Trevor & Roger Luddington. (1997). Reliability of delayed INR determination: implications for decentralized anticoagulant care with off‐site blood sampling. British Journal of Haematology. 96(3). 431–434. 36 indexed citations
17.
18.
Brown, Karen, Roger Luddington, David J. Williamson, Peter Baker, & Trevor Baglin. (1997). Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′‐untranslated region of the prothrombin gene. British Journal of Haematology. 98(4). 907–909. 133 indexed citations
19.
Luddington, Roger, Karen Brown, & Trevor Baglin. (1996). Effect of platelet phospholipid exposure on activated protein C resistance: implications for thrombophilia screening. British Journal of Haematology. 92(3). 744–746. 16 indexed citations
20.
Watson, Christopher J.E., et al.. (1993). THE PLATELET-ACTIVATING FACTOR ANTAGONIST WEB 2170 ITS BENEFICIAL EFFECT ON DOG RENAL ALLOGRAFT SURVIVAL. Transplantation. 56(4). 1047–1048. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Luddington Breakdown of academic impact, for papers by Patricia Vegh Breakdown of academic impact, for papers by Margareta Holmström Breakdown of academic impact, for papers by Joost J. van Veen Breakdown of academic impact, for papers by Caroline Baglin Breakdown of academic impact, for papers by Ian Jennings Breakdown of academic impact, for papers by H R Büller Breakdown of academic impact, for papers by Simon McRae Breakdown of academic impact, for papers by Dominique Lasne Breakdown of academic impact, for papers by E. C. M. van Pampus
Rankless by CCL
2026